BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
1.840
+0.040 (2.22%)
May 12, 2025, 4:00 PM - Market closed
BioRestorative Therapies Market Cap
BioRestorative Therapies has a market cap or net worth of $13.85 million as of May 12, 2025. Its market cap has increased by 61.00% in one year.
Market Cap
13.85M
Enterprise Value
3.11M
1-Year Change
61.00%
Ranking
Category
Stock Price
$1.84
Market Cap Chart
Since July 7, 2015, BioRestorative Therapies's market cap has decreased from $15.50M to $13.85M, a decrease of -10.67%. That is a compound annual growth rate of -1.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 13.50M | 36.36% |
| Dec 31, 2024 | 9.90M | 20.73% |
| Dec 29, 2023 | 8.20M | -18.81% |
| Dec 30, 2022 | 10.10M | -33.55% |
| Dec 31, 2021 | 15.20M | 7,500.00% |
| Dec 31, 2020 | 200.00K | - |
| Dec 31, 2019 | 200.00K | -97.87% |
| Dec 31, 2018 | 9.40M | -55.02% |
| Dec 29, 2017 | 20.90M | 39.33% |
| Dec 30, 2016 | 15.00M | 12.78% |
| Dec 31, 2015 | 13.30M | -14.19% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |